✦ LIBER ✦

Randomized double-blind comparison of omapatrilat with amlodipine in mild-to-moderate hypertension

✍ Scribed by L.M. Ruilope; P. Palatini; E. Grossman; D. Esposti; U. Speier; P.I. Chang; V. Gressin; F. Plat

Book ID: 117599093
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 164 KB
Volume: 13
Category: Article
ISSN: 0895-7061
DOI: 10.1016/s0895-7061(00)00596-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-blind comparison of amlodipine an

Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension

✍ C. Venkata S. Ram; Richard P. Ames; William B. Applegate; James F. Burris; Micha 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 734 KB

Multicenter, double-blind comparison of

Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension

✍ Peter Ott; Tommy L. Storm; Lars R. Krusell; Herluf Jensen; Jorgen Badskjaer; Ole 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 570 KB

Double-blind, crossover study of lercani

Double-blind, crossover study of lercanidipine versus amlodipine in the treatment of mild-to-moderate essential hypertension

✍ Lamberto A. De Giorgio; Francesco Orlandini; Paolo Malasoma; Alberto Zappa 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 602 KB

A randomized double-blind study of bisop

A randomized double-blind study of bisoprolol versus atenolol in mild to moderate essential hypertension

✍ M. S. Dixon; P. Thomas; D. J. Sheridan 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 447 KB

We have compared the efficacy and pharmacokinetics of bisoprolol, a new cardioselective beta-adrenoceptor antagonist, with atenolol in a randomized double-blind crossover study in 12 patients (mean age 53.5 y) with mild to moderate essential hypertension. After a two week placebo wash-out period wit

At equipotent doses, isradipine is bette

At equipotent doses, isradipine is better tolerated than amlodipine in patients with mild-to-moderate hypertension: a double-blind, randomized, parallel-group study.

✍ L Hermans; A Deblander; P de Keyser; I Scheys; E Lesaffre; KJ Westelinck 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 918 KB

Monotherapy treatment success rate of om

Monotherapy treatment success rate of omapatrilat, a vasopeptidase inhibitor, compared with lisinopril and amlodipine in mild to moderate hypertension

✍ H.R. Black; P.I. Chang; R.A. Reeves; W. Cooper; H. Pouleur 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 151 KB